Elderly patients with limited-stage small cell lung cancer (LS-SCLC) showed similar survival and toxicity compared to their younger counterparts when treated with concurrent chemo-radiotherapy.

Survivors, Advocates Kick Off Awareness Month at National Press Club Event

The International Association for the Study of Lung Cancer (IASLC) today issued a statement on lung cancer screening with low-dose computed tomography (LDCT)* based on results from the Dutch-Belgian NELSON lung cancer screening trial presented at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada.

Patients with metastatic NSCLC receiving treatment at academic centers (ACs) have an increased 2-year survival compared to patients treated at community-based centers (CCs).

We regretfully announce the resignation of Dr. Fred R. Hirsch from the IASLC CEO position effective Oct. 31, 2018, upon completion of his current five-year contract.

Free ME From Lung Cancer (FMFLC) and the International Association for the Study of Lung Cancer (IASLC) today announced the first ever winner of the FMFLC-IASLC Foundation Joint Fellowship Award for the Early Detection of Lung Cancer.